Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002012383-24-001259
Filing Date
2024-10-22
Accepted
2024-10-22 15:24:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 us2300311063_102224.txt SC 13G 12141
  Complete submission text file 0002012383-24-001259.txt   14172
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Subject) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91966 | Film No.: 241386145
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5300
BlackRock, Inc. (Filed by) CIK: 0002012383 (see all company filings)

EIN.: 991116001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)